Children's Oncology Group's 2013 blueprint for research: renal tumors - Wikidata - awgldk - TriplyDB

Children's Oncology Group's 2013 blueprint for research: renal tumors

Children's Oncology Group's 2013 blueprint for research: renal tumors

http://www.wikidata.org/entity/Q27000449

about

Pediatric genitourinary oncology Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumors Denys-Drash syndrome associated WT1 glutamine 369 mutants have altered sequence-preferences and altered responses to epigenetic modifications Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration Peptide spectra in Wilms tumor that associate with adverse outcomes Race disparities in peptide profiles of North American and Kenyan Wilms tumor specimens Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies.TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia.SIX2 Effects on Wilms Tumor Biology.Risk factors for abandonment of Wilms tumor therapy in Kenya.Wilms tumor with intravascular tumor thrombus.High dose therapy for recurrent Wilms' tumor Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors.Wilms Tumor: An Uncommon Entity in the Adult Patient Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic Malignancies Association of FOXM1 expression with tumor histology and prognosis in Wilms tumor: Potential for a new prognostic marker.Aberrant activation, nuclear localization, and phosphorylation of Yes-associated protein-1 in the embryonic kidney and Wilms tumor.FAK inhibition abrogates the malignant phenotype in aggressive pediatric renal tumors Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532.Gain of 1q is a marker of poor prognosis in Wilms' tumors.The correlation between LIN28B gene potentially functional variants and Wilms tumor susceptibility in Chinese children.Role for first zinc finger of WT1 in DNA sequence specificity: Denys-Drash syndrome-associated WT1 mutant in ZF1 enhances affinity for a subset of WT1 binding sites.Fanconi anemia and solid malignancies in childhood: a national retrospective study.Imaging of renal medullary carcinoma in children and young adults: a report from the Children's Oncology Group.Paediatrics: Integrating genomics to dig deeper into Wilms tumour biology.The impact of the lymph node density on overall survival in patients with Wilms' tumor: a SEER analysis.Malignant renal tumors in children.Extensive synchronous bilateral Wilms tumor treated with nephron sparing surgery.

P2860

Q27007650-DA7DC7F2-5DF8-4423-9371-FC24B248D152 Q27329466-C881FCAD-18A6-48DB-B931-1D04E8A0FE6C Q27728005-0138A571-59C8-4488-89AE-2E89A713A364 Q28083988-B6C2C43E-B3E7-43BD-9CD3-2122112F1692 Q30381395-B0418FCF-2DD7-49EA-9C48-6716B1189B6A Q30415295-75635536-C397-4FB8-8D15-20013CB21F40 Q33428775-F2011904-C6C0-4638-9E1E-921E6DFC24FD Q34338441-08F639C5-1D9C-4163-A289-5AAF9C657C4E Q35028775-8B42E6A3-8677-472B-A0E7-6C6BB582888C Q35587515-4F208B58-5BD3-4FDD-B350-938736577427 Q36508074-8BA928DA-5F3A-497D-8B14-B99037EA6D39 Q36508105-51F3806D-E1D8-4D9B-9500-D0708AD39FDD Q36709112-FA11BA23-BB6A-4687-9E38-61B579CFEE9F Q36903590-BF3D0CE1-0D4B-471B-A6BC-B081B7595AC6 Q36917809-E274FAFD-F1ED-43DF-A3F9-BA06CCFA7070 Q37288367-DFFA9BB3-B8E7-4FA3-8290-85B8279099F5 Q37639483-59A738D3-5CF1-4D6F-8CD7-C882AA5A9990 Q37707278-BF3355F1-1BBC-4C28-B141-A0D627D65481 Q38630842-D4420E3F-39D2-4CB8-BD7D-D0EED9CF3EE0 Q38998052-78841024-AA5C-4ED0-8DFD-073678516413 Q39349862-F91C6080-AAFF-4A80-B530-0A6AC4B347DA Q40289487-1B9ADDC4-ADBD-41E9-819C-12C9047D6E0C Q47238218-3218ACE7-F619-4F00-9942-8F6FF27AF343 Q48461365-B50E45C7-AA41-408A-8B97-4BEBFE7D1D5F Q49637075-39C06AE6-5EB8-4B50-80F6-9C900A6DD162 Q50080798-3ACD4AFC-883A-448C-AEDD-F11CFC768A92 Q52579362-C91459FA-D787-45BE-9C62-7A764EB26261 Q52979103-7CE121F2-86E1-423F-B33A-A77143FC6F6A Q55371722-94730477-2D68-4209-A2A6-527ADC37FF85

P2860

Children's Oncology Group's 2013 blueprint for research: renal tumors

http://www.wikidata.org/entity/Q27000449

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Children's Oncology Group's 2013 blueprint for research: renal tumors

@ast

Children's Oncology Group's 2013 blueprint for research: renal tumors

@en

Children's Oncology Group's 2013 blueprint for research: renal tumors

@nl

type

label

Children's Oncology Group's 2013 blueprint for research: renal tumors

@ast

Children's Oncology Group's 2013 blueprint for research: renal tumors

@en

Children's Oncology Group's 2013 blueprint for research: renal tumors

@nl

prefLabel

Children's Oncology Group's 2013 blueprint for research: renal tumors

@ast

Children's Oncology Group's 2013 blueprint for research: renal tumors

@en

Children's Oncology Group's 2013 blueprint for research: renal tumors

@nl

P1433

Q27000449-FB53DCAF-508D-4087-B532-05582B44AF1F

P1476

Q27000449-6DA047BB-9FDF-4726-8801-D98DB1A08021

P2093

Q27000449-05382AD5-26E9-4225-9D9D-611FE3155F81

Q27000449-2F136B86-618F-460C-9957-36C116B9FD18

Q27000449-2FF6F7AE-3866-40AC-A095-5FE6B8A45587

Q27000449-6FEC2FD3-6208-4FCE-BF01-7CB375ADC86E

Q27000449-71D9FEAC-0822-4AED-B4B8-64BD751F7DB0

Q27000449-82F0FA26-3A4C-4561-AC92-A170669FD80B

Q27000449-8B8F4BCA-543C-4F2F-AC0E-8422693E1C13

Q27000449-8E33A639-2CE9-437A-B91B-B0427F29298A

Q27000449-999CA291-C731-41DA-9BD2-AA5D08835779

Q27000449-A1046C4F-F3A6-4819-A8AF-587508B00867

P2860

Q27000449-00BCE387-EB7F-4690-A638-D9103E0EE433

Q27000449-0979872E-1A9D-4CDA-907B-AF84F6D45B0E

Q27000449-14619126-0EBF-4EFC-905D-BEC8F259EB52

Q27000449-17475980-9DC1-461C-81C9-79A0991937DF

Q27000449-175C4AE2-C24B-4104-94B8-97D2C06F4E75

Q27000449-1E5DAE89-A671-46E0-AA34-12A53F675A74

Q27000449-257BD110-CDC0-474D-A938-DADFC588E37F

Q27000449-25BB7964-186F-494D-B40E-8C7E4497B18A

Q27000449-2F810DC2-BF3E-47F9-9E86-CEFC2CD50C26

Q27000449-3A62827F-1971-4135-BC0D-DDDCE1E428E1

P304

Q27000449-F1336D89-A6AE-4603-9B93-8D163D7DE95A

P31

Q27000449-3835CECF-918B-47D6-B856-0CBE46627F8C

P3181

Q27000449-5FF26F93-F97C-49D5-BF29-FB11E35AAC40

P356

Q27000449-D695A84F-76A9-4FE2-A41F-F63082BF0107

P407

Q27000449-C3892919-CFAD-452D-90D9-4839EE2FC07B

P433

Q27000449-5AA2A333-3051-480D-A236-4902649751F4

P478

Q27000449-3FFDC043-8536-4F74-9F47-C088441A20D2

P50

Q27000449-665FDBF5-CD7D-43CF-81E8-C018CBFDCFF5

P577

Q27000449-77375F89-99D3-4FD6-A36F-A6A6239EB71C

P5875

Q27000449-FB8437BA-3C03-41F7-83AE-1939B61742A7

P698

Q27000449-1E6C921F-13CF-403E-8EFB-A17D58243B59

P932

Q27000449-D59902AF-7B71-436C-8B37-C09BA4EA4846

P3181

P356

P1433

Pediatric Blood & Cancer

P1476

Children's Oncology Group's 2013 blueprint for research: renal tumors

@en

P2093

Arlene Naranjo

http://www.w3.org/2001/XMLSchema#string

COG Renal Tumors Committee

http://www.w3.org/2001/XMLSchema#string

Conrad V Fernandez

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Mullen

http://www.w3.org/2001/XMLSchema#string

Elizabeth J Perlman

http://www.w3.org/2001/XMLSchema#string

Eric J Gratias

http://www.w3.org/2001/XMLSchema#string

Geetika Khanna

http://www.w3.org/2001/XMLSchema#string

James I Geller

http://www.w3.org/2001/XMLSchema#string

James R Anderson

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Dome

http://www.w3.org/2001/XMLSchema#string

P2860

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors

End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System.

Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group.

Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group.

Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group.

Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.

Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.

Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial.

Pregnancy outcome after treatment for Wilms tumor: a report from the national Wilms tumor long-term follow-up study.

P304

994-1000

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3685244

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/PBC.24419

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233958656

http://www.w3.org/2001/XMLSchema#string

P698

23255438

http://www.w3.org/2001/XMLSchema#string

P932

4127041

http://www.w3.org/2001/XMLSchema#string